Perencevich EN - Search Results

1

Co-carriage rates of vancomycin-resistant Enterococcus and extended-spectrum beta-lactamase-producing bacteria among a cohort of intensive care unit patients: implications for an active surveillance program.

Harris AD, Nemoy L, Johnson JA, Martin-Carnahan A, Smith DL, Standiford H, Perencevich EN. Harris AD, et al. Among authors: perencevich en. Infect Control Hosp Epidemiol. 2004 Feb;25(2):105-8. doi: 10.1086/502358. Infect Control Hosp Epidemiol. 2004. PMID: 14994933

2

National and regional assessment of the antibacterial soap market: a step toward determining the impact of prevalent antibacterial soaps.

Perencevich EN, Wong MT, Harris AD. Perencevich EN, et al. Am J Infect Control. 2001 Oct;29(5):281-3. doi: 10.1067/mic.2001.115469. Am J Infect Control. 2001. PMID: 11584251

3

Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients.

Harris AD, Perencevich E, Roghmann MC, Morris G, Kaye KS, Johnson JA. Harris AD, et al. Antimicrob Agents Chemother. 2002 Mar;46(3):854-8. doi: 10.1128/AAC.46.3.854-858.2002. Antimicrob Agents Chemother. 2002. PMID: 11850272 Free PMC article.

4

Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli.

Harris AD, Samore MH, Lipsitch M, Kaye KS, Perencevich E, Carmeli Y. Harris AD, et al. Clin Infect Dis. 2002 Jun 15;34(12):1558-63. doi: 10.1086/340533. Epub 2002 May 23. Clin Infect Dis. 2002. PMID: 12032889

5

Rates of hand disinfection associated with glove use, patient isolation, and changes between exposure to various body sites.

Kim PW, Roghmann MC, Perencevich EN, Harris AD. Kim PW, et al. Among authors: perencevich en. Am J Infect Control. 2003 Apr;31(2):97-103. doi: 10.1067/mic.2003.32. Am J Infect Control. 2003. PMID: 12665743

6

Assessing risks for a pre-emergent pathogen: virginiamycin use and the emergence of streptogramin resistance in Enterococcus faecium.

Smith DL, Johnson JA, Harris AD, Furuno JP, Perencevich EN, Morris JG Jr. Smith DL, et al. Among authors: perencevich en. Lancet Infect Dis. 2003 Apr;3(4):241-9. doi: 10.1016/s1473-3099(03)00581-4. Lancet Infect Dis. 2003. PMID: 12679267 Review.

7

Fluoroquinolone use and Clostridium difficile-associated diarrhea.

McCusker ME, Harris AD, Perencevich E, Roghmann MC. McCusker ME, et al. Emerg Infect Dis. 2003 Jun;9(6):730-3. doi: 10.3201/eid0906.020385. Emerg Infect Dis. 2003. PMID: 12781017 Free PMC article.

8

Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patients.

Kim PW, Harris AD, Roghmann MC, Morris JG Jr, Strinivasan A, Perencevich EN. Kim PW, et al. Among authors: perencevich en. Antimicrob Agents Chemother. 2003 Sep;47(9):2882-7. doi: 10.1128/AAC.47.9.2882-2887.2003. Antimicrob Agents Chemother. 2003. PMID: 12936989 Free PMC article.

9

Acceptable rates of treatment failure in osteomyelitis involving the diabetic foot: a survey of infectious diseases consultants.

Perencevich EN, Kaye KS, Strausbaugh LJ, Fisman DN, Harris AD; Infectious Diseases Society of America Emerging Infections Network. Perencevich EN, et al. Clin Infect Dis. 2004 Feb 15;38(4):476-82. doi: 10.1086/381029. Epub 2004 Jan 26. Clin Infect Dis. 2004. PMID: 14765338

10

Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem.

Smith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA. Smith DL, et al. Among authors: perencevich en. Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3709-14. doi: 10.1073/pnas.0400456101. Epub 2004 Feb 25. Proc Natl Acad Sci U S A. 2004. PMID: 14985511 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

287 results

Search Page